5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: A multimechanism therapeutic approach? [4] (multiple letters)

Luca Sigalotti, Maresa Altomonte, Francesca Colizzi, Massimo Degan, Maurizio Rupolo, Vittorina Zagonel, Antonio Pinto, Valter Gattei, Michele Maio, Michael Lübbert, Pierre W. Wijermans, Peter A. Jones, Eva Hellström-Lindberg

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)4644-4646
Number of pages3
JournalBlood
Volume101
Issue number11
DOIs
Publication statusPublished - Jun 1 2003

ASJC Scopus subject areas

  • Hematology

Cite this

Sigalotti, L., Altomonte, M., Colizzi, F., Degan, M., Rupolo, M., Zagonel, V., Pinto, A., Gattei, V., Maio, M., Lübbert, M., Wijermans, P. W., Jones, P. A., & Hellström-Lindberg, E. (2003). 5-Aza-2′-deoxycytidine (decitabine) treatment of hematopoietic malignancies: A multimechanism therapeutic approach? [4] (multiple letters). Blood, 101(11), 4644-4646. https://doi.org/10.1182/blood-2002-11-3458